George Medicines

George Medicines is a late-stage drug development company spun out from The George Institute for Global Health. It focuses on improving the management of non-communicable diseases through proprietary, innovative, single-pill fixed-dose combinations of existing drugs. George Medicines is developing proprietary therapies that have the potential to significantly enhance clinical outcomes and treatment adherence for patients with cardiometabolic diseases such as heart disease, hypertension, and diabetes.